Vimarsana
Biggest News Aggregation in the World

Stempoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stempoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stempoint Capital Today - Breaking & Trending Today

CARGO Therapeutics (NASDAQ:CRGX) Trading Down 9.4% - Vimarsana News

CARGO Therapeutics (NASDAQ:CRGX) Trading Down 9.4%

Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX – Get Free Report) fell 9.4% on Tuesday . The company traded as low as $18.52 and last traded at $18.90. 48,484 shares were traded during trading, a decline of 80% from the average session volume of 242,179 shares. The stock had previously closed at $20.86. Analyst Upgrades and […]

CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Reaffirmed by Truist Financial - Vimarsana News

CARGO Therapeutics (NASDAQ:CRGX) Stock Rating Reaffirmed by Truist Financial

Truist Financial reaffirmed their buy rating on shares of CARGO Therapeutics (NASDAQ:CRGX – Free Report) in a research note released on Thursday morning, Benzinga reports. The firm currently has a $32.00 target price on the stock, down from their prior target price of $34.00. Separately, Jefferies Financial Group boosted their price objective on CARGO Therapeutics […]

Here Are Some Of The Best Ideas From The 2024 Sohn New York Conference - Vimarsana News

Here Are Some Of The Best Ideas From The 2024 Sohn New York Conference

Rising star: Michelle Ross on Crinetics Pharmaceuticals Like in many other years, this year's Sohn New York conference kicked off with several "Next Wave" speakers,

Source: forbes.com
Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing - Vimarsana News

Protara Therapeutics Announces Oversubscribed $45 Million Private Placement Financing

NEW YORK, April 05, 2024 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative thera...

Dianthus Therapeutics Announces $230 Million Private Placement - Vimarsana News

Dianthus Therapeutics Announces $230 Million Private Placement

NEW YORK and WALTHAM, Mass., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (“Dianthus” or the “Company”) (NASDAQ: DNTH), a clini...